Synovo GmbH Details

Synovo GmbH

Company Profile:

Synovo GmbH is a drug discovery company focussing on pre-clinical services in medicinal chemistry and in vivo pharmacology. 

Synovo's pre-clinical services include:
Pharmacokinetics
Disease models:  Auto-immune models, osteoporosis, neuropathic pain, osteoarthritis, metabolism and diabetes, and a range of CNS phenomena including trauma, inflammation and neurodegeneration

Synovo's medicinal chemistry services include:
Preparation of literature compounds
Experimental formulation
Medicinal chemistry at either library level, or specific analogue production


Synovo's niche is the provision of integrated pre-clinical project support with the objective of providing our partners with fast and flexible data in early stage discovery projects.  Through our combination of synthetic chemistry and in-vivo pharmacology, we can generate the multi faceted early stage data that a project requires including synthesis or formulation of substances, pharmacokinetics (minimal compound use), rapid efficacy models and proof of concept models including advanced imaging via PET, CT or MRI.

Our business concept is to replicate the skill base found in discovery project teams such that our partners can obtain comprehensive solutions via a single interface.

Previous Clients:

Synovo has a range of clients including:

7 biotechs

3 mid-size pharma

2 large pharma

Key Products:

• Pharmacology
• Disease models in rodents
• Pharmacokinetics
• Toxicology foresight and formulation

Medicinal chemistry:

• Analog synthesis
• Literature compound preparation
• Experimental formulation

Website:
www.synovo.com